• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[晚期小肺癌的外科治疗研究]

[Study of surgical treatment of advanced small lung cancer].

作者信息

Suyama M, Kunishima K, Takagi I, Shinoda M, Karasawa K

机构信息

Department of Thoracic Surgery, Aichi Cancer Center Hospital.

出版信息

Kyobu Geka. 1991 Jan;44(1):28-32.

PMID:2038142
Abstract

We analyzed 15 patients with small but advanced primary lung cancer operated from 1965 to 1988. The size of tumors were less than 2.0 cm in largest dimension and their pathological stages III A, III B and IV. The histological types were adenocarcinoma in 13 cases and squamous cell carcinoma in 2 cases. Nine patients (69%) had elevated levels of preoperative serum CEA. The prognosis of patients with intrapulmonary metastases was better than that of those with pleural dissemination. In adenocarcinoma patients with mediastinal lymph node metastases, the survival rate of cases with small cancer less than 2.0 cm in diameter was higher than those with large cancer more than 5.0 cm in diameter.

摘要

我们分析了1965年至1988年期间接受手术的15例小型但已进展的原发性肺癌患者。肿瘤最大直径小于2.0厘米,病理分期为ⅢA期、ⅢB期和Ⅳ期。组织学类型为腺癌13例,鳞状细胞癌2例。9例患者(69%)术前血清癌胚抗原水平升高。肺内转移患者的预后优于胸膜播散患者。在有纵隔淋巴结转移的腺癌患者中,直径小于2.0厘米的小癌患者的生存率高于直径大于5.0厘米的大癌患者。

相似文献

1
[Study of surgical treatment of advanced small lung cancer].[晚期小肺癌的外科治疗研究]
Kyobu Geka. 1991 Jan;44(1):28-32.
2
[Surgical treatment of advanced (p-stage III.IV) lung cancer less than 2.0 cm in size].[直径小于2.0厘米的晚期(p分期III、IV期)肺癌的外科治疗]
Kyobu Geka. 1991 Jan;44(1):73-6.
3
[Results of the surgical treatment of patients with advanced small lung cancer].
Kyobu Geka. 1991 Jan;44(1):47-50.
4
Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement.直径2厘米及以下的周围型小尺寸非小细胞肺癌肿瘤切除标本的临床病理研究:胸膜侵犯及血清癌胚抗原水平升高作为淋巴结受累的预测指标
J Thorac Cardiovasc Surg. 2006 May;131(5):988-93. doi: 10.1016/j.jtcvs.2005.12.035.
5
[Surgical results of small sized (less than 3 cm) advanced lung cancer].[小尺寸(小于3厘米)进展期肺癌的外科手术结果]
Kyobu Geka. 1991 Jan;44(1):85-8.
6
Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.非小细胞肺癌最高纵隔淋巴结转移的预后意义
Ann Thorac Surg. 2006 Jan;81(1):292-7. doi: 10.1016/j.athoracsur.2005.06.077.
7
[Surgical treatment of pathological stage III and IV in non-small cell lung cancer with peripheral tumor of 3 cm or less in diameter].
Kyobu Geka. 1991 Jan;44(1):51-5.
8
Surgical treatment for lung cancer with metastasis to mediastinal lymph nodes.伴有纵隔淋巴结转移的肺癌的外科治疗。
J Thorac Cardiovasc Surg. 1976 Feb;71(2):279-85.
9
Can tumor size be a guide for limited surgical intervention in patients with peripheral non-small cell lung cancer? Assessment from the point of view of nodal micrometastasis.肿瘤大小能否作为周围型非小细胞肺癌患者有限手术干预的指导?基于淋巴结微转移角度的评估。
J Thorac Cardiovasc Surg. 2001 Nov;122(5):900-6. doi: 10.1067/mtc.2001.117626.
10
[Surgical treatment of pathological stage III and IV lung cancer less than 3 cm in diameter].直径小于3厘米的Ⅲ期和Ⅳ期肺癌的外科治疗
Kyobu Geka. 1991 Mar;44(3):215-8.